Fate Therapeutics, Inc. (FATE) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Fate Therapeutics, Inc., with annual and quarterly history.
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Valuation | ||||||
| P/E Ratio | -0.86x | -1.01x | -2.29x | -3.47x | -26.13x | -43.21x |
| P/B Ratio | 0.56x | 0.59x | 1.00x | 2.02x | 8.17x | 19.49x |
| P/S Ratio | 17.56x | 13.76x | 5.79x | 10.15x | 99.27x | 238.32x |
| Profitability | ||||||
| Gross Margin | -94.1% | 100.0% | -147.4% | 85.7% | 89.5% | -299.6% |
| Operating Margin | -2222.4% | -1542.6% | -299.9% | -320.2% | -388.6% | -407.5% |
| Net Margin | -2051.1% | -1366.5% | -253.3% | -292.5% | -379.9% | -551.6% |
| EBITDA Margin | -1911.2% | -1295.4% | -271.1% | -305.9% | -378.1% | -397.7% |
| Liquidity | ||||||
| Current Ratio | 5.79x | 7.58x | 8.48x | 4.40x | 7.79x | 5.78x |
| Quick Ratio | 5.79x | 7.58x | 8.48x | 4.40x | 7.79x | 5.78x |
| Leverage | ||||||
| Debt/Equity | 0.38x | 0.27x | 0.28x | 0.23x | 0.17x | 0.25x |
YoY = year-over-year change. Source: FMP..